Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
VM26 therapy in children with drug-refractory lymphocytic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'VM26 therapy in children with drug-refractory lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Combination Chemotherapy
100%
Cytotoxic Activity
100%
Drug Refractory
100%
Early Relapse
100%
Future Role
100%
High Risk
100%
Leukemia Cells
100%
Leukemia Patients
100%
Lymphocytic Leukemia
100%
Remission Induction
100%
Treatment Strategy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
50%
Cytotoxicity
50%
Leukemia
100%
Lymphatic Leukemia
100%
Remission
50%
Teniposide
100%
Medicine and Dentistry
Combination Chemotherapy
50%
Cytotoxicity
50%
Leukemia
50%
Leukemia Cell
50%
Lymphoid Leukemia
100%
Spontaneous Remission
50%
Teniposide
100%